DIFLUNISAL (Rising Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the DIFLUNISAL drug offered from Rising Pharmaceuticals Inc.. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rising Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | DIFLUNISAL |
| SUBSTANCE NAME: | DIFLUNISAL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-05-01 |
| END MARKETING DATE: | 0000-00-00 |
DIFLUNISAL HUMAN PRESCRIPTION DRUG Details:
| Item Description | DIFLUNISAL from Rising Pharmaceuticals Inc. |
| LABELER NAME: | Rising Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2012-05-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64980-181_5a68ac1c-94bd-4583-8c87-38618bd3f2a0 |
| PRODUCT NDC: | 64980-181 |
| APPLICATION NUMBER: | ANDA202845 |
Other DIFLUNISAL Pharmaceutical Manufacturers / Labelers:
